Conway woman awaits double lung transplant to survive long COVID
One Conway woman is continuing to fight for her life after being diagnosed with Pulmonary Fibrosis in her battle with long ...
Pliant Therapeutics Provides Update on BEACON-IPF, a Phase 2b/3 Trial in Patients with Idiopathic Pulmonary Fibrosis
Following DSMB recommendation, the Company has voluntarily paused enrollment and dosing in the BEACON-IPF Phase 2b trial and ...
pulmonaryfibrosisnews8h
Low cholesterol levels linked to worse outcomes in IPF: Study
Low total cholesterol levels were tied to an increased risk of death for pulmonary fibrosis patients with disease of unknown cause in a study.
Insmed's NDA for Lung Disease Drug Gets FDA's Priority Review
The FDA accepts and grants priority review to INSM's NDA for brensocatib to treat patients with non-cystic fibrosis bronchiectasis. A decision is due on Aug. 12, 2025.
News Medical on MSN21h
Early immune system changes contribute to lung damage in cystic fibrosis
Despite new medication, cystic fibrosis often leads to permanent lung damage. Working with an international team, researchers from the Technical University of Munich (TUM) have discovered that the ...